New evaluation of plasma DNA microsatellite analysis in patients with TCC of the urinary bladder

Anticancer Research

Volumn 24, Issue 3 A, 2004, Pages 1733-1736

  Fornari, Delfina ^a   Steven, Kenneth ^a   Hansen, Alastair B ^a   Vibits, Henrik ^a   Jepsen, Jan V ^a   Poulsen, Asger L ^a   Schwartz, Marianne ^b   Horn, Thomas ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Bladder; LOH; Microsatellites; MSI; Plasma

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CAPILLARY ELECTROPHORESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DNA DETERMINATION; GENE AMPLIFICATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LASER; LEUKOCYTE; MICROSATELLITE INSTABILITY; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; DNA, NEOPLASM; GENE AMPLIFICATION; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; PROSTATIC HYPERPLASIA; URINARY BLADDER NEOPLASMS;

EID: 3242740287     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Stroun M, Anker P, Lyautey J, Lederrey C and Maurice PA: Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clin Oncol 23: 707-712, 1987.
2. Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C and Beljanski M: Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46: 318-322, 1989.
3. Ziegler A, Zangemeister-Wittke U and Stahel RA: Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev 28: 255-271, 2002.
4. Anker P, Mulcahy H and Stroun M: Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies? Int J Cancer 103: 149-152, 2003.
5. Orntoft TF and Wolf H: Molecular alterations in bladder cancer. Urol Res 26: 223-233, 1998.
6. Goessl C, Muller M, Straub B and Miller K: DNA alterations in body fluids as molecular tumor markers for urological malignancies. Eur Urol 41: 668-676, 2002.
7. Dahse R, Utting M, Werner W, Schimmel B, Claussen U and Junker K: TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples. Int J Oncol 20: 107-115, 2002.
8. Utting M, Werner W, Dahse R, Schubert J and Junker K: Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer. Clin Cancer Res 8: 35-40, 2002.
9. Bergkvist A, Ljungqvist A and Moberger G: Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 130: 371-378, 1965.
10. Chen XQ, Stroun M, Magnenat JL et al: Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 2: 1033-1035, 1996.
11. Canzian F, Salovaara R, Hemminki A et al: Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 56: 3331-3337, 1996.
12. Cawkwell L, Bell SM, Lewis FA, Dixon MF, Taylor GR and Quirke P: Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 67: 1262-1267, 1993.
13. Findlay I, Ray P, Quirke P, Rutherford A and Lilford R: Allelic drop-out and preferential amplification in single cells and human blastomeres: implications for preimplantation diagnosis of sex and cystic fibrosis. Hum Reprod 10: 1609-1618, 1995.
14. Habuchi T, Ogawa O, Kakehi Y, Ogura K, Koshiba M, Hamazaki S, Takahashi R, Sugiyama T and Yoshida O: Accumulated allelic losses in the development of invasive urothelial cancer. Int J Cancer 53: 579-584, 1993.